02/14/2025
12:17 PM | AlloVir (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/10/2025
11:15 PM | AlloVir (Filer)
| Form EFFECT | |
02/10/2025
3:19 PM | AlloVir (Filer)
| Form 424B3 | |
01/24/2025
1:51 PM | AlloVir (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2025
1:55 PM | AlloVir (Subject)
Miller Edward (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2025
2:03 PM | AlloVir (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/15/2025
3:39 PM | AlloVir (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/15/2025
3:41 PM | AlloVir (Subject)
| Form 425 | |
01/13/2025
3:15 PM | AlloVir (Issuer)
Sinha Vikas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
3:15 PM | AlloVir (Issuer)
Hagen Brett R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
3:15 PM | AlloVir (Issuer)
Miller Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ALVR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for AlloVir and its competitors with MarketBeat's FREE daily newsletter. |
01/10/2025
7:00 PM | AlloVir (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2025
7:00 PM | AlloVir (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2025
7:00 PM | AlloVir (Subject)
Miller Edward (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2025
6:44 AM | AlloVir (Subject)
| Form 425 | |
01/10/2025
6:42 AM | AlloVir (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2024
3:21 PM | AlloVir (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2024
3:23 PM | AlloVir (Subject)
| Form 425 | |
12/11/2024
4:07 PM | AlloVir (Issuer)
Miller Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
5:37 AM | AlloVir (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
12/06/2024
8:50 PM | AlloVir (Subject)
| Form 425 | |
12/06/2024
6:23 AM | AlloVir (Filer)
| Form DEF 14A | |
11/20/2024
3:15 PM | AlloVir (Issuer)
Brainard Diana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
3:15 PM | AlloVir (Issuer)
Miller Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
3:15 PM | AlloVir (Issuer)
Sinha Vikas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
3:15 PM | AlloVir (Issuer)
Hagen Brett R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
7:00 PM | AlloVir (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/19/2024
7:00 PM | AlloVir (Subject)
Brainard Diana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/19/2024
7:00 PM | AlloVir (Subject)
Miller Edward (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/19/2024
7:00 PM | AlloVir (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024
3:05 PM | AlloVir (Subject)
| Form 425 | |
11/08/2024
3:06 PM | AlloVir (Subject)
| Form 425 | |
11/08/2024
3:09 PM | AlloVir (Subject)
| Form 425 | |
11/08/2024
3:10 PM | AlloVir (Subject)
| Form 425 | |
11/08/2024
7:26 AM | AlloVir (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
7:33 AM | AlloVir (Subject)
| Form 425 | |
11/05/2024
7:00 PM | AlloVir (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/05/2024
7:00 PM | AlloVir (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/05/2024
7:00 PM | AlloVir (Subject)
Miller Edward (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/05/2024
7:00 PM | AlloVir (Subject)
Brainard Diana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024
3:15 PM | AlloVir (Issuer)
Miller Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad) If you missed out on the big boom in Nvidia…
Listen up, because according to Nvidia's own CEO…
Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry. You MUST act before March 17th. |
10/23/2024
3:15 PM | AlloVir (Issuer)
Hagen Brett R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2024
3:15 PM | AlloVir (Issuer)
Sinha Vikas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2024
3:15 PM | AlloVir (Issuer)
Brainard Diana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
7:00 PM | AlloVir (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/22/2024
7:00 PM | AlloVir (Subject)
Miller Edward (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/22/2024
7:00 PM | AlloVir (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/21/2024
7:00 PM | AlloVir (Subject)
Miller Edward (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/21/2024
7:00 PM | AlloVir (Subject)
Brainard Diana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/21/2024
7:00 PM | AlloVir (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/21/2024
7:00 PM | AlloVir (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/04/2024
3:15 PM | AlloVir (Issuer)
Hagen Brett R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
3:15 PM | AlloVir (Issuer)
Brainard Diana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
3:15 PM | AlloVir (Issuer)
Miller Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
3:15 PM | AlloVir (Issuer)
Sinha Vikas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
7:00 PM | AlloVir (Subject)
Miller Edward (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024
7:00 PM | AlloVir (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024
7:00 PM | AlloVir (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024
7:00 PM | AlloVir (Subject)
Brainard Diana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2024
3:15 PM | AlloVir (Issuer)
Brainard Diana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
10:14 AM | AlloVir (Subject)
Brainard Diana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
3:15 PM | AlloVir (Issuer)
Brainard Diana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:15 PM | AlloVir (Issuer)
Sinha Vikas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:15 PM | AlloVir (Issuer)
Hagen Brett R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:15 PM | AlloVir (Issuer)
Miller Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
7:00 PM | AlloVir (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
7:00 PM | AlloVir (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
7:00 PM | AlloVir (Subject)
Miller Edward (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
7:00 PM | AlloVir (Subject)
Brainard Diana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2024
8:05 AM | AlloVir (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024
3:15 PM | AlloVir (Issuer)
Hagen Brett R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
3:15 PM | AlloVir (Issuer)
Sinha Vikas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
3:15 PM | AlloVir (Issuer)
Brainard Diana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
3:15 PM | AlloVir (Issuer)
Miller Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
7:00 PM | AlloVir (Subject)
Miller Edward (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/06/2024
7:00 PM | AlloVir (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/06/2024
7:00 PM | AlloVir (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/06/2024
7:00 PM | AlloVir (Subject)
Brainard Diana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/02/2024
5:25 PM | AlloVir (Subject)
Invus Global Management, LLC (Filed by)
| Form SC 13G/A | |
07/23/2024
3:25 PM | AlloVir (Issuer)
Miller Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2024
3:27 PM | AlloVir (Issuer)
Sinha Vikas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2024
3:28 PM | AlloVir (Issuer)
Brainard Diana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2024
3:28 PM | AlloVir (Issuer)
Hagen Brett R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2024
7:00 PM | AlloVir (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/22/2024
7:00 PM | AlloVir (Subject)
Miller Edward (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/22/2024
7:00 PM | AlloVir (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/19/2024
7:00 PM | AlloVir (Subject)
Miller Edward (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/19/2024
7:00 PM | AlloVir (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/19/2024
7:00 PM | AlloVir (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/19/2024
7:00 PM | AlloVir (Subject)
Brainard Diana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/02/2024
7:00 PM | AlloVir (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Do this Before Elon’s Reveal on March 17th (Ad) Elon’s newest tech could pay you an extra $30,000 a year — while you sleep.
It’s smaller than a quarter but designed to power a $9 trillion AI revolution.
And I’ve identified a little-known supplier Elon is depending on to make it all happen. I urge you to watch this video now. |
07/02/2024
6:30 PM | AlloVir (Subject)
Miller Edward (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/02/2024
6:30 PM | AlloVir (Subject)
Brainard Diana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/02/2024
6:30 PM | AlloVir (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024
4:10 PM | AlloVir (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2024
4:24 PM | AlloVir (Issuer)
Brainard Diana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
7:00 PM | AlloVir (Subject)
Brainard Diana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/21/2024
3:35 PM | AlloVir (Issuer)
Hagen Brett R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
3:33 PM | AlloVir (Issuer)
Miller Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
3:33 PM | AlloVir (Issuer)
Sinha Vikas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
